BioXcel Therapeutics, Inc. – Plans of Reorganization, Merger, Acquisition or Similar

OTC: BTAIQ
Share price (11/5/26): $0.01
Market cap (11/5/26): $275 thousand

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 92 pages Asset Purchase Agreement by and Among BioXcel Therapeutics, Inc., Onkosxcel Therapeutics, LLC, Onkosxcel Employee Holdings, LLC, Teva Pharmaceuticals International Gmbh and Teva Pharmaceutical Industries Limited (Solely for Purposes of Section 9.16) Dated as of August 27, 2026

from SC 13D 19 pages BioXcel Holdings, Inc. Termination Agreement